Abstract

Muscular dystrophies result from a defect in the linkage between the muscle fiber cytoskeleton and the basement membrane (BM). Congenital muscular dystrophy type MDC1A is caused by mutations in laminin ?2 that either reduce its expression or impair its ability to polymerize within the muscle fiber BM. Defects in this BM lead to muscle fiber damage from the force of contraction. In this issue of the JCI, McKee and colleagues use a laminin polymerization-competent, designer chimeric BM protein in vivo to restore function of a polymerization-defective laminin, leading to normalized muscle structure and strength in a mouse model of MDC1A. Delivery of such a protein to patients could ameliorate many aspects of their disease.

Original languageEnglish
Pages (from-to)798-800
Number of pages3
JournalJournal of Clinical Investigation
Volume127
Issue number3
DOIs
StatePublished - Mar 1 2017

Fingerprint

Dive into the research topics of 'Muscular dystrophy meets protein biochemistry, the mother of invention'. Together they form a unique fingerprint.

Cite this